Status regarding Novo Nordisk's holding of its own shares (30 June 2017)
Bagsværd, Denmark, 3 July 2017 - In continuation of the company's announcements dated 2 February 2017 and 3 May 2017 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 30 June 2017 owned 26,782,349 of its own B shares of DKK 0.20, corresponding to a total nominal value of DKK 5,356,470 or 1.1% of the total share capital.
In the second quarter of 2017 a total of 13,768,358 B shares were repurchased, and 17,871 B shares were disposed to employees in connection with employee incentive programmes.
Further information
| Media: | ||
| Anne Margrethe Hauge | +45 4442 3450 | amhg@novonordisk.com |
| Ken Inchausti (US) | +1 609 786 8316 | kiau@novonordisk.com |
| Investors : | ||
| Peter Hugreffe Ankersen | +45 3075 9085 | phak@novonordisk.com |
| Hanna Ögren | +45 3079 8519 | haoe@novonordisk.com |
| Anders Mikkelsen | +45 3079 4461 | armk@novonordisk.com |
| Kasper Veje (US) | +1 609 235 8567 | kpvj@novonordisk.com |
Company announcement No 53 / 2017
Attachments:
